Algo version: 0.98b
ACRV is listed at the NASDAQ Exchange
ACRV [ACRV]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is ACRV stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Acrivon Therapeutics, 10 years ago, but if you had invested on Wednesday 9th of November 2022 when the price was $0.0000, you would have made a profit of $8.13 per share or 81 299 900.00%

Yes, the average daily trading liquidity for Acrivon Therapeutics, is $1.03 million. You should therefore be able to get in and out of your positions relatively fast.

Acrivon Therapeutics, has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Acrivon Therapeutics, to be medium [0.7 out of 1]